Literature DB >> 11062344

Human Dermo-1 has attributes similar to twist in early bone development.

M S Lee1, G Lowe, S Flanagan, K Kuchler, C A Glackin.   

Abstract

Basic helix-loop-helix (bHLH) transcription factors are implicated in cell lineage determination and differentiation. Dermo-1 encodes a bHLH transcription factor that shares extensive homology with another bHLH transcription factor, Twist. We have cloned and characterized human Dermo-1 from two different bone cytoplasmic DNA (cDNA) libraries. Dermo-1 mRNA and protein expression were examined in human embryo and adult tissue sections. Dermo-1 is expressed in a subset of mesodermally and ectodermally derived tissues. We further examined expression of Dermo-1/Twist in human tissues and cell lines. In addition, we observed Dermo-1 expression in response to basic fibroblast growth factor in osteoblastic cell lines. To evaluate the functionality of the human Dermo-1 transcription factor in osteoblast metabolism, we made stable osteoblastic cell lines that over- and underexpress human Dermo-1. These cell lines were analyzed and compared with previously published data of similar cell lines transfected with Twist. Our results demonstrate that Dermo-1 caused changes similar to Twist in the osteogenic properties of osteoblastic cells, such as morphology, bone marker gene expression, and biochemical response to cytokines. However, Dermo-1 expression also has unique effects in regulating the mechanism of proliferation, on alkaline phosphatase enzyme activity, and in temporal expression patterns. We speculate that expression of Twist and Dermo-1 maintains cells in an osteoprogenitor or preosteoblast-like state, respectively, and prevents premature or ectopic osteoblast differentiation. Therefore, Twist and Dermo-1 must be sequentially downregulated in order to initiate the cascade of events responsible for osteogenic cell differentiation. These results indicate that, during osteoblast development, Dermo-1 may inhibit osteoblast maturation and maintain cells in a preosteoblast phenotype by utilizing mechanisms similar but not identical to those utilized by Twist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062344     DOI: 10.1016/s8756-3282(00)00380-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  28 in total

1.  A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development.

Authors:  E W Jabs
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Phylogenetic and evolutionary relationships and developmental expression patterns of the zebrafish twist gene family.

Authors:  Gare Hoon Yeo; Felicia S H Cheah; Christoph Winkler; Ethylin Wang Jabs; Byrappa Venkatesh; Samuel S Chong
Journal:  Dev Genes Evol       Date:  2009-06-30       Impact factor: 0.900

3.  Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels.

Authors:  Wen-Tzu Lai; Veena Krishnappa; Donald G Phinney
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

4.  Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.

Authors:  Erika Rosivatz; Ingrid Becker; Katja Specht; Elena Fricke; Birgit Luber; Raymonde Busch; Heinz Höfler; Karl-Friedrich Becker
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Twist2 is a valuable prognostic biomarker for colorectal cancer.

Authors:  Hao Yu; Guang-Zhi Jin; Kai Liu; Hui Dong; Hua Yu; Ji-Cheng Duan; Zhe Li; Wei Dong; Wen-Ming Cong; Jia-He Yang
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

6.  Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.

Authors:  Hiu-Fung Yuen; Yuen-Piu Chan; Michelle Lok-Yee Wong; Wei-Kei Kwok; Ka-Kui Chan; Pin-Yin Lee; Gopesh Srivastava; Simon Ying-Kit Law; Yong-Chuan Wong; Xianghong Wang; Kwok-Wah Chan
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

7.  Nonsense mutations of the bHLH transcription factor TWIST2 found in Setleis Syndrome patients cause dysregulation of periostin.

Authors:  Hector L Franco; Jose J Casasnovas; Ruth G Leon; Robert Friesel; Yongchao Ge; Robert J Desnick; Carmen L Cadilla
Journal:  Int J Biochem Cell Biol       Date:  2011-07-27       Impact factor: 5.085

8.  Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c.

Authors:  Yun Sok Lee; Hyoung Ho Lee; Jiyoung Park; Eung Jae Yoo; Carlotta A Glackin; Young Il Choi; Sung Ho Jeon; Rho Hyun Seong; Sang Dai Park; Jae Bum Kim
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

9.  TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.

Authors:  G Yin; R Chen; A B Alvero; H-H Fu; J Holmberg; C Glackin; T Rutherford; G Mor
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

10.  Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: Role of exosomes in horizontal transfer of Twist1.

Authors:  Li Chen; Ruju Chen; Sherri Kemper; Alyssa Charrier; David R Brigstock
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-30       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.